Effects of a standardized Ayurvedic formulation on diabetes control in newly diagnosed Type-2 diabetics; a randomized active controlled clinical study

2015 ◽  
Vol 23 (4) ◽  
pp. 555-561 ◽  
Author(s):  
Harshika Awasthi ◽  
Rajendra Nath ◽  
Kauser Usman ◽  
Dayanandan Mani ◽  
Sanjay Khattri ◽  
...  
2021 ◽  
Author(s):  
Punam Khobarkar ◽  
Jayant Gulhane ◽  
Amit Nakanekar

Abstract Type 2 Diabetes mellitus in obese persons is becoming threatening disease due to increasing prevalence of its microvascular and macro vascular complications. A multi targeted treatment can be considered better over single targeted treatment; in view of multiple pathways involved in pathogenesis of diabetes and its complications. This open labelled randomized controlled clinical Study was aimed to evaluate clinical efficacy of ‘Vidangadi Lauha’(An Ayurveda formulation) in comparison with metformin for obese type II diabetes mellitus. Participants were divided into two groups. Trial group received Vidangadi Lauha 5gm BID and control group received tablet metformin 500mg BID for duration of 3 months. Among 550 screened participants 120 participants were eligible, out of them 100 participants were enrolled and randomized by computer generated method, out of them 80 patients (40 in each group) completed the trial. Both the treatments were equally effective in reducing blood sugar fasting(F), post meal(PM) glycated Haemoglobin (HbA1C) and Body Mass Index (BMI). Vidangadi Lauha is more effective in reducing Ayurvedic Symptoms, waist hip ratio and cholesterol as compared to Metformin. High Density Lipoproteins (HDL) were improved by minor clinical difference in both the groups. Both the treatment does not have statistically significant effect in reducing Low Density Lipoproteins (LDL).


2019 ◽  
Vol 493 ◽  
pp. S283-S284
Author(s):  
R. Sharma ◽  
P. Sharma ◽  
S. Sharma ◽  
S. Ravichandran ◽  
P. Kamble ◽  
...  

2014 ◽  
Vol 14 (1) ◽  
pp. 39-42
Author(s):  
Rashi Khare ◽  
Narender S Senger

Background: Diabetes mellitus (DM) is a major health problem with long-term microvascular and macrovascular complications responsible for the majority of its mortality and morbidity. The development and progression of diabetic complications are strongly related to the degree of glycemic control. The purpose of this study was to study, the incidence of retinopathy in newly diagnosed diabetics and its association with various risk factors with a special stress on role of HbA1c levels. Methods: We analysed 300 newly diagnosed type2 diabetics (diagnosed within 6 months). Patients were subject to detailed history, examination (including retinal examination), and investigations including serum creatinine, urinary micro-albumin, 24 hours urinary protein, HbA1c and ultrasonography. Results: Incidence of retinopathy in newly diagnosed type 2 diabetics was 30% (91/300). With increase in HbA1c, the incidence of retinopathy increased. All results were statistically proven. Conclusion: Incidence of retinopathy in newly diagnosed type2 diabetics is as high as 30%. Glycemic control is the an important factor contributing to development of this microvascular complications in diabetic patients. DOI: http://dx.doi.org/10.3329/bjms.v14i1.16535 Bangladesh Journal of Medical Science Vol.14(1) 2015 p.39-42


Sign in / Sign up

Export Citation Format

Share Document